Advancing outcomes of metastatic HER2-positive breast cancer. Chumsri S. Lancet 2023 Apr 19:S0140-6736(23)00805-X. doi: 10.1016/S0140-6736(23)00805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chumsri S. Advancing outcomes of metastatic HER2-positive breast cancer. Lancet 2023 Apr 19:S0140-6736(23)00805-X. doi: 10.1016/S0140-6736(23)00805.
PMID: 37086743